Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Queensland Health
Cantor Fitzgerald
Express Scripts
Dow
Deloitte
Chinese Patent Office
Colorcon

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,457,895

« Back to Dashboard

Summary for Patent: 5,457,895
Title: Method of identifying freeze-dried dosage forms
Abstract:The invention permits the application of an identifying mark onto a freeze-dried tablet without the need for application of pressure or for printing directly on the tablet. The invention comprises the preparation of a freeze-dried unit that is embossed with an identifying mark such as a manufacturer's logo, medicinal component strength, or other information relating to the unit. The desired identifying mark is first embossed onto the base of a container such as a blister pocket. Liquid suspension is then filled into the container and freeze-dried therein. The resulting freeze-dried unit in the container is thereby embossed with substantial copy of the identifying mark that was embossed on the base of the container. The embossed identifying mark on the base of the container remains thereon as well, providing at reduced manufacturing cost the added ability to learn the identifying mark on the enclosed freeze-dried unit without opening the blister pack.
Inventor(s): Thompson; Andrew R. (Swindon, GB3), Yarwood; Richard J. (Buckland, GB3), Kearney; Patrick (Swindon, GB3)
Assignee: R. P. Scherer Corporation (Troy, MI)
Application Number:08/104,486
Patent Claim Types:
see list of patent claims
Use; Dosage form; Process;

Drugs Protected by US Patent 5,457,895

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,457,895

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 197542 ➤ Try a Free Trial
Australia 7801494 ➤ Try a Free Trial
Canada 2149659 ➤ Try a Free Trial
Germany 69426305 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Cipla
US Army
Argus Health
Chubb
Fuji
Federal Trade Commission
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.